Skip to main
CBMG
CBMG logo

Cellular Biomedicine Group (CBMG)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy CBMG Stock

About Cellular Biomedicine Group (CBMG)

Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD.
Market cap$384.15M
Today's volume
Revenue (TTM)
Avg. daily volume88.65K
EBITDA (TTM)
Open
Price / earnings ratio-6.98x
Today's range
Debt / equity
52 week range$11.48 - $19.76
5 year debt / equity12.02x
Beta (LTM)0.91x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsNov 9, 2020
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 16, 2025, the market cap for CBMG stock is $384.15M

The current P/E ratio for CBMG stock is -6.98

The 52-week high for CBMG stock is $19.76. The current CBMG stock price $undefined is 100.00% below its 52-week high

The 52-week low for CBMG stock is $11.48. The current CBMG stock price $undefined has increased 100.00% from its 52-week low

No, the CBMG stock does not pay dividends to its shareholders

How to buy CBMG stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CBMG stock

    Navigate to the Explore page. Then, type CBMG into the search bar. When you see CBMG stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CBMG stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Cellular Biomedicine Group Stock Earnings

The value each CBMG share was expected to gain vs. the value that each CBMG share actually gained.

CBMG (CBMG) reported Q4 2019 earnings per share (EPS) of -$0.65, beating estimates of -$0.74 by 12.16%. In the same quarter last year, CBMG's earnings per share (EPS) was $0. CBMG is expected to release next earnings on 11/09/2020, with an earnings per share (EPS) estimate of $0.

Buy CBMG Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.